Numerous studies have attempted to untangle the complex relationship between SCD1 and the progression of a variety of diseases, including obesity and diabetes (40), cardiovascular diseases (41, 42), and cancer (43). Here, SCD is linked to obesity due to melanocortin 4 receptor deficiency.